Table 2 Knowledge, and clinical experience regarding MIH etiology, management, and perceived need for training
Questions | N (%) | P-value | |
|---|---|---|---|
Which factor(s) do you think are involved in the etiology of MIH? | Genetic factors Chronic medical condition(s) that affect the mother during pregnancy Chronic medical condition(s) that affect the involved child Antibiotics/medications taken by the mother during pregnancy Antibiotics/medications taken by the involved child Environmental contaminants Acute medical condition(s) that affect the mother during pregnancy Acute medical condition(s) that affect the involved child Fluoride exposure | 447 (28.5%) # 264 (16.9%) 105 (6.7%) 219 (14.0%) 79 (5.0%) 227 (14.5%) 103 (6.6%) 43 (2.7%) 79 (5.0%) | < 0.001* |
Which material do you use MOST in treating MIH molars? | Amalgam Compomer Composite resin Resin Modified GIC Flowable composite resin Preformed crowns High Fluoride GIC Glass Ionomer Cement ICON | 6 (1.2%) 21 (4.2%) 226 (45.2%) # 137 (27.4%) 5 (1.0%) 47 (9.4%) 48 (9.6%) 9 (1.8%) 1 (0.2%) | < 0.001* |
Which factors influence your choice of restorative material? | Adhesion Remineralization potential Aesthetics Sensitivity Patient/parent preference Personal experience Durability Research findings | 163 (21.8%) 108 (14.4%) 207 (27.7%) # 73 (9.8%) 28 (3.7%) 9 (1.2%) 132 (17.6%) 28 (3.7%) | < 0.001* |
Do you think MIH is a clinical problem? (yes) | 290 (96.3%) | < 0.001* | |
If yes, what do you experience problems with? | Diagnosis Aesthetics Achieving adequate local anesthesia Determining the restorative margins of affected enamel Providing adequate restorations Long-term success of restorations Achieving patient comfort (for function, oral hygiene) | 115 (16.3%) 206 (29.3%) # 119 (16.9%) 59 (8.4%) 28 (4.0%) 159 (22.6%) 18 (2.6%) | < 0.001* |
Would you suggest including clinical training regarding MIH in your dental course? (yes) | 475 (95.0%) | < 0.001* | |
If yes, in which area(s) do you think you need to know/be taught about the most? | Diagnosis Etiology Treatment Prevention Complications | 386 (36.8%) 216 (20.6%) 441 (42.0%) # 5 (0.5%) 1 (0.1%) | < 0.001* |